S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ENVB Enveric Biosciences Inc

1.70

0.00 (0.00%)

Pre Market

Last Updated: 03:00:03

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Enveric Biosciences (NASDAQ:ENVB)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Enveric Biosciences Charts.

Enveric Biosciences (NASDAQ:ENVB)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Enveric Biosciences Charts.

Enveric Biosciences Inc News

Form 8-K - Current report
Thursday 6 March 2025 (6 days ago) • Edgar (US Regulatory)

Enveric Biosciences CEO Issues Letter to Shareholders
Thursday 27 February 2025 (2 weeks ago) • Business Wire

This Biotech Soared On Key Announcement
Wednesday 26 February 2025 (2 weeks ago) • AllPennyStocks.com

Form 8-K - Current report
Wednesday 26 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Enveric Biosciences Unveils EVM401 Series of Compounds with New U.S. Patent
Tuesday 25 February 2025 (2 weeks ago) • Business Wire

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Wednesday 5 February 2025 (1 month ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Tuesday 4 February 2025 (1 month ago) • Edgar (US Regulatory)

Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease
Tuesday 4 February 2025 (1 month ago) • Business Wire

Form 8-K - Current report
Monday 3 February 2025 (1 month ago) • Edgar (US Regulatory)

Enveric Biosciences Announces Closing of $5 Million Public Offering
Monday 3 February 2025 (1 month ago) • Business Wire

Form 424B4 - Prospectus [Rule 424(b)(4)]
Monday 3 February 2025 (1 month ago) • Edgar (US Regulatory)

Enveric Biosciences Announces Pricing of $5 Million Public Offering
Thursday 30 January 2025 (1 month ago) • Business Wire

More Enveric Biosciences Inc News Articles

Fundo Invest Imobiliario...

FIL Fund Management Irel...

BNP Paribas Issuance

Societe Generale Effekten

Societe Generale Effekten

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions